Hyundai Bioscience Co., Ltd. (KOSDAQ: 048410)
South Korea
· Delayed Price · Currency is KRW 13,950
-300 (-2.11%)
Dec 19, 2024, 9:00 AM KST
Hyundai Bioscience Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Other Revenue | -0 | -0 | - | - | - | 0 | Upgrade
|
| Revenue | 15,818 | 9,481 | 7,852 | 9,241 | 12,511 | 30,086 | Upgrade
|
| Revenue Growth (YoY) | 57.22% | 20.76% | -15.04% | -26.14% | -58.41% | -3.68% | Upgrade
|
| Cost of Revenue | 3,813 | 4,490 | 5,140 | 6,012 | 6,104 | 16,554 | Upgrade
|
| Gross Profit | 12,005 | 4,992 | 2,712 | 3,229 | 6,408 | 13,532 | Upgrade
|
| Selling, General & Admin | 8,300 | 7,846 | 6,542 | 6,647 | 6,283 | 6,728 | Upgrade
|
| Research & Development | 3,349 | 6,401 | 16,456 | 4,763 | 1,968 | 1,290 | Upgrade
|
| Other Operating Expenses | 39.02 | 42.25 | 27.37 | 61.28 | 40.98 | 85.61 | Upgrade
|
| Operating Expenses | 11,926 | 14,795 | 29,023 | 12,519 | 10,838 | 11,112 | Upgrade
|
| Operating Income | 78.78 | -9,804 | -26,311 | -9,289 | -4,430 | 2,420 | Upgrade
|
| Interest Expense | -1,385 | -314.57 | -448.65 | -3,003 | -1,130 | -774.02 | Upgrade
|
| Interest & Investment Income | 368.4 | 669.19 | 536.69 | 291.71 | 195.91 | 146.26 | Upgrade
|
| Earnings From Equity Investments | -4,745 | - | 8,834 | 93.91 | 1,542 | -166.12 | Upgrade
|
| Currency Exchange Gain (Loss) | -38.38 | -68.67 | 48.15 | 20.39 | -102.31 | 156.51 | Upgrade
|
| Other Non Operating Income (Expenses) | -72.44 | -335.47 | -182.82 | -404.46 | -1,179 | -31.12 | Upgrade
|
| EBT Excluding Unusual Items | -5,794 | -9,853 | -17,524 | -12,291 | -5,104 | 1,751 | Upgrade
|
| Gain (Loss) on Sale of Investments | 123.67 | 123.67 | 910.99 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | - | -3.5 | Upgrade
|
| Asset Writedown | -4,769 | -4,769 | - | -7,517 | -2,829 | - | Upgrade
|
| Pretax Income | -10,439 | -14,498 | -16,613 | -19,808 | -7,933 | 1,748 | Upgrade
|
| Income Tax Expense | 1.09 | 1.04 | -805.47 | 243.5 | 326.46 | 178.85 | Upgrade
|
| Earnings From Continuing Operations | -10,440 | -14,499 | -15,807 | -20,051 | -8,260 | 1,569 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | - | - | -447.66 | Upgrade
|
| Net Income | -10,440 | -14,499 | -15,807 | -20,051 | -8,260 | 1,121 | Upgrade
|
| Net Income to Common | -10,440 | -14,499 | -15,807 | -20,051 | -8,260 | 1,121 | Upgrade
|
| Net Income Growth | - | - | - | - | - | -57.16% | Upgrade
|
| Shares Outstanding (Basic) | 40 | 40 | 39 | 37 | 36 | 35 | Upgrade
|
| Shares Outstanding (Diluted) | 40 | 40 | 39 | 37 | 36 | 35 | Upgrade
|
| Shares Change (YoY) | 0.18% | 1.04% | 6.64% | 2.79% | 3.67% | 2.75% | Upgrade
|
| EPS (Basic) | -262.21 | -364.53 | -401.53 | -543.16 | -229.99 | 32.37 | Upgrade
|
| EPS (Diluted) | -262.85 | -365.00 | -402.00 | -543.16 | -230.00 | 32.37 | Upgrade
|
| EPS Growth | - | - | - | - | - | -58.31% | Upgrade
|
| Free Cash Flow | 4,975 | -6,548 | -18,087 | -4,285 | -17,702 | 6,113 | Upgrade
|
| Free Cash Flow Per Share | 124.96 | -164.62 | -459.44 | -116.08 | -492.91 | 176.47 | Upgrade
|
| Gross Margin | 75.89% | 52.65% | 34.54% | 34.95% | 51.22% | 44.98% | Upgrade
|
| Operating Margin | 0.50% | -103.40% | -335.10% | -100.52% | -35.41% | 8.04% | Upgrade
|
| Profit Margin | -66.00% | -152.92% | -201.33% | -216.97% | -66.02% | 3.73% | Upgrade
|
| Free Cash Flow Margin | 31.45% | -69.06% | -230.36% | -46.37% | -141.49% | 20.32% | Upgrade
|
| EBITDA | 751.35 | -8,369 | -24,529 | -6,586 | -652.3 | 6,233 | Upgrade
|
| EBITDA Margin | 4.75% | -88.27% | - | -71.27% | -5.21% | 20.72% | Upgrade
|
| D&A For EBITDA | 672.57 | 1,435 | 1,782 | 2,703 | 3,778 | 3,813 | Upgrade
|
| EBIT | 78.78 | -9,804 | -26,311 | -9,289 | -4,430 | 2,420 | Upgrade
|
| EBIT Margin | 0.50% | -103.40% | - | -100.52% | -35.41% | 8.04% | Upgrade
|
| Effective Tax Rate | - | - | - | - | - | 10.23% | Upgrade
|
| Advertising Expenses | - | 996.63 | 965.59 | 1,497 | 798.47 | 1,568 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.